Latest & greatest articles for elderly

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on elderly or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on elderly and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for elderly

21. The State of Ageing in 2019: Adding life to our years

occupations. Pessimism about getting older is also linked to poorer health. People who worry about their health getting worse and those who expect to get lonely are around 30% more likely to have a negative experience of ageing than people who don’t. 31 8% 6% 5% 3% 3% 25 to 34 year olds 50 to 64 year olds 35 to 49 year olds 65 to 74 year olds 75 and over professional occupations routine occupations 7% 20% Later lives todayHow will future generations experience later life? In less than 20 years, the number (...) at risk. HealthHousing The majority of people continue to live in mainstream houses as they grow older, rather than moving into specialist accommodation, and increasing numbers of over 50s are renting. Yet UK housing stock is by and large unsuitable for people to grow old in.The State of Ageing in 2019 Adding life to our years 27 Housing With 38% of our homes dating from before 1946 (21% from before 1919), and just 7% from after 2000, the UK has the oldest housing stock in the EU. 69 Unsurprisingly

2020 The Centre for Ageing Better

22. Efficacy, safety, and tolerability of mirabegron in patients aged >/=65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR)

. Safety and tolerability were consistent with the known mirabegron safety profile. Conclusions: Mirabegron efficacy, safety, and tolerability over 12 wk were confirmed in patients aged ≥65yr with OAB and incontinence. Patient summary: We examined the effect of mirabegron compared with placebo in people aged 65yr or older with overactive bladder and incontinence. Mirabegron improved the symptoms of overactive bladder compared with placebo. Side effects were similar to those already known for mirabegron (...) of Mirabegron in Patients Aged ≥65yr With Overactive Bladder Wet: A Phase IV, Double-Blind, Randomised, Placebo-Controlled Study (PILLAR) Adrian Wagg et al. Eur Urol . Feb 2020 Show details Eur Urol Actions , 77 (2), 211-220 Authors , , , , , Affiliations 1 Geriatric Medicine, University of Alberta, Edmonton, Alberta, Canada. Electronic address: adrian.wagg@ualberta.ca. 2 Division of Urology, St Elizabeth's Medical Center, Boston, MA, USA. 3 Bayview Research Group, LLC, Valley Village, CA, USA. 4 Sunnybrook

2020 EvidenceUpdates

23. Mortality Implications of Prediabetes and Diabetes in Older Adults

delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Diabetes Care Actions , 43 (2), 382-388 Feb 2020 Mortality Implications of Prediabetes and Diabetes in Older Adults , , , , , , , Affiliations Expand Affiliations 1 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 2 Division of Cardiology and National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland. 3 Department of Geriatric (...) @jhu.edu. PMID: 31776141 PMCID: (available on 2021-02-01 ) DOI: Item in Clipboard Full-text links Cite Abstract Objective: Diabetes in older age is heterogeneous, and the treatment approach varies by patient characteristics. We characterized the short-term all-cause and cardiovascular mortality risk associated with hyperglycemia in older age. Research design and methods: We included 5,791 older adults in the Atherosclerosis Risk in Communities Study who attended visit 5 (2011-2013; ages 66-90 years

2020 EvidenceUpdates

24. State of Ageing 2019 infographics

and Chelsea Disability free life expectancy Total life expectancySource: +"CFMMBOE/"NJO4NJUIFUBM 5IF%ZOBNJDTPG"HF JOH &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF 1 in 5 people aged 55-64 have a health problem that limits the kind of work they can doSource: +"CFMMBOE/"NJO4NJUIFUBM 5IF%ZOBNJDTPG"HF JOH &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF More than a quarter of the poorest men aged 50 and over are smokers, compared to 5% of the wealthiest 27% 5% 5% 19% 1 oor FTURu J O UJMe 8 FB (...) &WJEFODFGSPNUIF&OHMJTI-POHJUVEJOBM4UVEZPG"HFJOH 8BWF Compared to the wealthiest quintile, the poorest quintile of men aged 50 and over are: 3x 2x 2x NPr FMJ L e M Z U o h B W e chronic heart disease N or FMJ L e M Z U o h B W e Type 2 diabetes N or FMJ L e M Z U o h BWe arthritis4PVSDF0tDFPG/BUJPOBM4UBUJTUJDT .FBTVSJOHOBUJPOBMXFMMCFJOH EPNBJOTBOENFBTVSFT CBTFE - POFMJOFTTB T FDUT QFPQMFP GBMMBHFT 8% 6% 5% 3% 3% 25 to 34 year olds 50 to 64 year olds 35 to 49 year olds 65 to 74 year olds 75 and over

2020 The Centre for Ageing Better

25. Measuring ageing: An introduction to the Ageing Better Measures Framework

Better 2019 Local monitoring and evaluation We are also making use of the ABMF at a local level. We are working with the Greater Manchester Combined Authority, Leeds City Council and Leeds Older People’s Forum, supporting them, as well as other members of the UK Network of Age-Friendly Communities, in their use of data and measures to understand local experiences of ageing and monitor progress. We look forward to continuing to work with these and other partners interested in measuring what matters (...) Measuring ageing: An introduction to the Ageing Better Measures Framework Measuring ageing: An introduction to the Ageing Better Measures Framework Centre for Ageing Better January 20193 © Centre for Ageing Better 2019 About the Centre for Ageing Better The Centre for Ageing Better is a charity, funded by an endowment from The National Lottery Community Fund, working to create a society where everyone enjoys a good later life. We want more people to be in fulfilling work, in good health, living

2020 The Centre for Ageing Better

26. COVID-19: Rapidly managing pneumonia in older people during a pandemic

adults is preferable to treating it. Identification of the early stages of pneumonia in older patients can prove difficult. Traditional symptoms and signs, including fever, may be absent. Limited evidence suggests that many tests that are useful in younger patients do not help . The onset of pneumonia in elderly people can often be rapid, and the prognosis is poor in severe pneumonia: The older you are, the more prevalent becomes. Patients in appear to fare even worse, as they often have several (...) comorbidities and poor nutritional status and are often physically inactive. In-hospital mortality is significantly higher, even after adjusting for age and sex. Common causative organisms in elderly people admitted to hospital with pneumonia include Streptococcus pneumoniae and Mycoplasma pneumoniae . Less commonly, Haemophilus influenzae and Staphylococcus aureus may be responsible. In severe pneumonia, S. aureus , Klebsiella pneumoniae , and Pseudomonas aeruginosa are common causative organisms

2020 Oxford COVID-19 Evidence Service

27. COVID-19 and medicines advice for older people

COVID-19 and medicines advice for older people COVID-19 and medicines advice for older people | British Geriatrics Society Toggle main menu visibility Search Search Search COVID-19 and medicines advice for older people Stay at home advice: Feedback on this resource? Email If you’d like us to contact you, please leave your email Your feedback * CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Other resources in this series (...) Contact us British Geriatrics Society Marjory Warren House 31 St John’s Square London EC1M 4DN Tel: +44 (0)20 7608 1369 Fax: +44 (0)20 7608 1041 Quick links Follow us Sign up for our e-bulletin Built by

2020 British Geriatrics Society

28. COVID-19: Geriatric basics for non-specialists

COVID-19: Geriatric basics for non-specialists COVID-19: Geriatric basics for non-specialists | British Geriatrics Society Toggle main menu visibility Search Search Search COVID-19: Geriatric basics for non-specialists Delirium Comprehensive Geriatric Assessment (CGA) External materials These materials have been developed by external organisations for people who are not necessarily specialists in geriatric medicine or the healthcare of older people and may be of use in some clinical and non (...) . Current advice Other resources in this series Contact us British Geriatrics Society Marjory Warren House 31 St John’s Square London EC1M 4DN Tel: +44 (0)20 7608 1369 Fax: +44 (0)20 7608 1041 Quick links Follow us Sign up for our e-bulletin Built by

2020 British Geriatrics Society

29. Preventing respiratory illness in older adults aged 60 years and above living in long-term care

Preventing respiratory illness in older adults aged 60 years and above living in long-term care Preventing respiratory illness in older adults aged 60 years and above living in long-term care - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Preventing respiratory illness in older adults aged 60 years and above living in long-term care March 28, 2020 Patricia Rios, Amruta Radhakrishnan, Sonia M. Thomas (...) ) or mixed evidence of effectiveness (e.g., rimantadine, zanamivir, hand hygiene, personal protective equipment). The mixed evidence on hand hygiene and use of personal protective equipment does not imply these should not be used in outbreaks BACKGROUND The Infection Prevention & Control of the World Health Organization (WHO) Health Emergency Programme commissioned a review on preventing and managing COVID-19 in older adults aged 60 years and above living in long-term care facilities. The overall

2020 Oxford COVID-19 Evidence Service

30. Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care

Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care March 28, 2020 Patricia (...) , these recommendations should be viewed with caution as it is unclear how many of these guidelines are based on the best available evidence due to their poor overall quality. BACKGROUND The Infection Prevention & Control of the World Health Organization (WHO) Health Emergency Programme commissioned a review on preventing and managing COVID-19 in older adults aged 60 years and above living in long-term care facilities. The overall objective of this rapid review of clinical practice guidelines was to identify

2020 Oxford COVID-19 Evidence Service

31. [Efficacy of a reconciliation intervention by a specialized pharmacist to resolve medication-related problems of elderly patients admitted to an emergency department short-stay unit: a randomized clinical trial]. (Abstract)

[Efficacy of a reconciliation intervention by a specialized pharmacist to resolve medication-related problems of elderly patients admitted to an emergency department short-stay unit: a randomized clinical trial]. To determine the effect on medication-related problems (MRPs) of a process of medication reconciliation carried out by a specialized pharmacist for patients aged 65 years or older admitted to an emergency department short-stay unit (SSU).Randomized clinical trial of 17 months (February (...) 2013-June 2014) in the SSU of a hospital emergency department. Patients were aged 65 years or older at high risk of MRPs. A total of 130 patients were randomized to a control group (n = 65) or the intervention group (n = 65). The reconciliation process (intervention) was carried out by a specialized pharmacist. The main outcome was the number of MRPs resolved in each group.A total of 3081 medications for 130 patients were reviewed. The patients' mean (SD) age was 79 (7.6) years and 66 (50.8%) were

2019 Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias Controlled trial quality: uncertain

32. Older Adults' Functional Performance and Health Knowledge After a Combination Exercise, Health Education, and Bingo Game. Full Text available with Trip Pro

Older Adults' Functional Performance and Health Knowledge After a Combination Exercise, Health Education, and Bingo Game. Combining exercise, health education, and the game of bingo may help older adults remain independent. The objective was to determine whether a 10-week health promotion program (Bingocize®) improves functional performance and health knowledge in older adults. Participants were assigned to experimental (n = 13) or control (n = 14) groups. The intervention was administered (...) twice per week at two independent living facilities. Pre and postfunctional performance and health knowledge were measured. Mixed between-within subject ANOVA was used to detect differences between groups (p < .05). Improvements were found in all dependent variables except lower body flexibility, systolic blood pressure, and health knowledge. Adherence was 97.31% ± 2.59%. Bingocize® has the potential to help older adults remain independent by improving functional performance. Statistical

2019 Gerontology & geriatric medicine Controlled trial quality: uncertain

33. Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program. Full Text available with Trip Pro

Treatment for Advanced Cancer (NEXTAC) and the impact on QOL in elderly patients with advanced cancer.We recruited 30 patients aged ≥70 years who were scheduled to receive the first-line chemotherapy for newly diagnosed advanced pancreatic or non-small-cell lung cancer. The QOL was assessed using the European Organization for Research and Treatment of Cancer QOL Questionnaire version 3.0, while the PA was measured using a pedometer/accelerometer. Instructors counseled patients to increase daily activity (...) Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise Treatment for Advanced Cancer Program. Physical activity (PA) may improve the quality of life (QOL) of cancer survivors. However, the impact on patients with advanced cancer with high cachectic potential is unknown. We analyzed the feasibility of PA intervention using the multimodal program Nutrition and Exercise

2019 Asia-Pacific journal of oncology nursing Controlled trial quality: uncertain

34. Impact of Moderate Aerobic Training on Physical Capacities of Hypertensive Obese Elderly. Full Text available with Trip Pro

Impact of Moderate Aerobic Training on Physical Capacities of Hypertensive Obese Elderly. The association of old age and chronic conditions, such as hypertension and obesity, can lead to larger decreases in the physical capacities of elderly, compared with their healthy counterparts. Physical exercise has been demonstrated to be efficient in postponing this phenomenon, mainly strength training. However, little is known about the effect of aerobic training on this condition. The aim of this work (...) was to investigate the impact of 12 weeks of moderate-intensity aerobic training on the physical capacities of hypertensive obese older women. Aerobic power, lower limb muscle power, upper limb muscle strength, endurance, and flexibility of 19 hypertensive obese elders were evaluated. Afterward, patients were blindly randomized into control group (CG) and exercise group (EG). EG underwent three sessions/week of 60 min of moderate-intensity aerobic training, during 12 weeks. EG showed increases in VO2max compared

2019 Gerontology & geriatric medicine Controlled trial quality: uncertain

35. Feasibility and preliminary effects of an integrated hospital-to-home transitional care intervention for older adults with stroke and multimorbidity: A study protocol. Full Text available with Trip Pro

Feasibility and preliminary effects of an integrated hospital-to-home transitional care intervention for older adults with stroke and multimorbidity: A study protocol. Stroke is a major life-altering event and the leading cause of death and disability in Canada. Most older adults who have suffered a stroke will return home and require ongoing rehabilitation in the community. Transitioning from hospital to home is reportedly very stressful and challenging, particularly if stroke survivors have (...) multiple chronic conditions. New interventions are needed to improve the quality of transitions from hospital to home for this vulnerable population.The primary objective of this study is to examine the feasibility of implementing a new 6-month transitional care intervention supported by a web-based app. The secondary objective is to explore its preliminary effects.A single arm, pre/post, pragmatic feasibility study of 20-40 participants in Ontario, Canada. Participants will be community-dwelling older

2019 Journal of comorbidity Controlled trial quality: uncertain

36. Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older

Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve (...) accepted all cookies. You can at any time. Hide Search Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older The Commission on Human Medicines has issued a series of recommendations to strengthen measures to minimise risk with the yellow fever vaccine (Stamaril) following very rare fatal reactions. Key recommendations include new and updated contraindications and strengthened precautions to protect those with a weakened immune systems (including

2019 MHRA Drug Safety Update

37. Elexacaftor/ivacaftor/tezacaftor (Trikafta) - To treat patients 12 years of age and older with the most common gene mutation that causes cystic fibrosis

Elexacaftor/ivacaftor/tezacaftor (Trikafta) - To treat patients 12 years of age and older with the most common gene mutation that causes cystic fibrosis Drug Approval Package: TRIKAFTA TRIKAFTA " /> U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: TRIKAFTA Company: Vertex Pharmaceuticals Inc. Application Number: 212273 Approval Date: 10/18/2019 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 (...) for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review Files (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) (PDF) Date created: November 25, 2019 Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance. Note: Documents in PDF format require the . Note: If you need help accessing information in different file formats, see . Language Assistance Available: | | | | | | | | | | | | | | | FDA Popular Content Product Areas

2019 FDA - Drug Approval Package

38. Palliative Care for Geriatric Trauma Patients, Trauma Center Care and Routine Processes for Care - Evidence-Based Review

to in- crease somewhere between the ages 55 and 65 years, 6 and the American College of Surgeons Committee on Trauma recom- mends consideration for triage to TCs for patients 55 years or older.However,muchofthefocusedgeriatrictraumaliterature usesage65yearsorevenolderwhenexamininginterventions. For this reason, we chose to focus on interventions targeting adults 65 years or older. OBJECTIVES Thepurposeofthisreviewwastoprovideasystematicre- viewof 2 key issues in care of the geriatric trauma patient: TC (...) in the definition of elderly, which hampers studyinclusiondefinitions;ouruseoftheage65yearswasmost common,butthismayhaveimpactedourfindings.However,de- spite these limitations, most studies supported similar conclu- sions with at least a modest effect size, allowing us to make somerecommendations for clinicalpractice. UsingTheseGuidelinesinClinicalPractice As our older adult population increases, injured geriatric patientswillcontinuetoposechallengesforcare,suchascomor

2019 Eastern Association for the Surgery of Trauma

39. Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines Full Text available with Trip Pro

Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines As a person's age increases and his/her health status declines, new challenges arise that may lead physicians to consider deprescribing statins. We aimed to provide insight into recommendations available in international cardiovascular disease prevention guidelines regarding discontinuation of statin treatment applicable to older adults.We systematically searched PubMed, EMBASE, EMCARE (...) , and the websites of guideline development organizations and online guideline repositories for cardiovascular disease prevention guidelines aimed at the general population. We selected all guidelines with recommendations (instructions and suggestions) on discontinuation of statin treatment applicable to older adults, published between January 2009 and April 2019. In addition, we performed a synthesis of information from all other recommendations for older adults regarding statin treatment. Methodological

2019 EvidenceUpdates

40. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis Full Text available with Trip Pro

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular risk irrespective of age, but the evidence is less strong for older patients.This prespecified analysis from ODYSSEY OUTCOMES compared the effect of alirocumab vs. placebo in 18 924 patients with recent acute coronary syndrome (ACS) according to age. We examined the effect of assigned (...) frequent in older patients, there were no differences between alirocumab and placebo.In patients with recent ACS, alirocumab improves outcomes irrespective of age. Increasing absolute benefit but not harm with advancing age suggests that LDL-C lowering is an important preventive intervention for older patients after ACS.© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Cardiology.

2019 EvidenceUpdates